Jerez de la Frontera

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Asthma1 trial
• Metastatic breast cancer1 trial

Phase

• Phase 31 trial

Status

• Completed1 trial
• Terminated1 trial

Lead sponsor

• AstraZeneca2 trials

Closed trials

• Completed

  Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment

  NCT06750289· Phase 3· AstraZeneca· Source

• Terminated

  An Observational Study of Patients Receiving T-DXd for Treatment of HER2+, and HER2-low Unresectable and/or Metastatic Breast Cancer

  NCT05592483· AstraZeneca· Source